Back

News and reflections from the world of AI

    Christina Caira reflects on use of AI in Parkinson’s disease research

    Introduction Parkinson’s disease (PD) is the second most common neurodegenerative disorder, characterized by the degeneration of dopamine releasing ...
    Written by Aiforia

    Doctoral student Polina Stepanova discusses benefits of AI in Huntington's Disease image analysis

    What is Huntington's Disease? Huntington's disease (HD) is a progressive brain disorder caused by a single defective gene, called huntingtin. Over ...
    Written by Aiforia

    Neuroscientist Joan Compte discusses benefits of AI in Parkinson’s disease image analysis

    What is PD? Parkinson’s disease (PD) is a neurological disorder characterized by the degeneration of dopamine releasing regions in the brain. The ...
    Written by Aiforia
    April 19, 2021

    Entrevista con el Dr. Jose Lanciego

    English Director Científico del Laboratorio de Neuroanatomía del Centro de Investigación Médica Aplicada de la Universidad de Navarra, Pamplona, España.
    Written by Aiforia
    April 19, 2021

    Interview with Dr. Jose Lanciego

    Español Staff Scientist and Director, Laboratory of Functional Basal Ganglia Neuroanatomy Center for Applied Medical Research at the University of Navarra, Pamplona, Spain
    Written by Aiforia
    October 27, 2020

    Van Andel Institute case study: quantitative, unbiased assessment of alpha-synuclein immunoreactivity with AI

    Why did you decide to use Aiforia’s AI software and services? Christopher: We recognized that Aiforia could provide us a uniform, fully quantitative, unbiased way to analyze the presence of a specific marker of pathogenic α-synuclein that is a key hallmark of Parkinson’s disease. We had previously used several different analysis methods to assess pathogenic α-synuclein immunoreactivity in the ...
    Written by Aiforia
    1 2 3